AccUrine is a platform company, established by Yael Schneidman & Shani Shenhar Tsarfaty, spacialised in Rapid At-Home and Point-of-Care Diagnostic Solutions via Urine
AccUrine revolutionizes diagnostics by using urine to deliver advanced, non-invasive testing that is accessible to all.
Our technology empowers individuals, supports clinicians, and transforms how diseases are detected, monitored, and managed worldwide.
AccUrine deciphers the signals of the body’s immune system, providing clinicians with actionable insights to support more informed treatment decisions and improve outcomes. Urine was chosen over blood because it offers a non-invasive, pain-free collection method that is more convenient and allows for easy, repeated testing when needed.
We utilize machine learning, advanced algorithms, and clinical expertise to analyze immune system signals in urine, accurately measuring biomarkers associated with a range of clinical conditions
